Drug protein discovery company Bright Peak hopes to deliver conjugated cancer immunotherapies based on an ETH Zürich-invented platform.

University of Louisville, University of Kentucky and Kentucky Science and Technology will extend their tech transfer expertise to other local institutions.

Co-founded by faculty from Columbia University and University of Melbourne, Praxis Precision Medicines targets CNS disorders.

Novo Holdings returned for a $110m series C1 round for Praxis Precision Medicines, four months after the gene therapy developer emerged from stealth with $100m in funding.

Danaher Life Sciences and Agilent Technology joined existing backers Merck Group and Illumina for a $50m series B extension that increased the round’s total to nearly $89m.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Indigo Diabetes increased its total funding to $52.6m with a series B round backed by Ackermans & van Haaren.

Enthera Pharmaceuticals was co-founded by faculty from University of Milan and is using stem cells to treat autoimmune disorders.

CureVac has filed for an initial public offering in the US, 20 years after being spun out of Eberhard Karls University of Tübingen.

Forbes-backed online pharmacy Ro has received $200m in funding led by General Catalyst, trebling its valuation to $1.5bn.